Paris, September 10, 2024 – Eclevar MedTech, a leading Contract Research Organization (CRO) specializing in medical devices and in vitro diagnostics, is proud to announce its selection by Unither Pharmaceuticals to lead their upcoming clinical studies on their medical devices. This collaboration marks a significant milestone in the partnership between the two companies, aimed at enhancing innovation and efficiency in healthcare.
Unither Pharmaceuticals, a global leader in pharmaceutical and medical device contract manufacturing, chose Eclevar for its recognized expertise in managing clinical trials and its ability to navigate the complex regulations of the medical device industry. Founded in 1993, with production sites in France, the United States, China, and Brazil, as well as an R&D center in Bordeaux, Unither is renowned for its advanced technologies, such as blow-fill-seal (BFS) and liquid stick-packs.
Eclevar MedTech, based in Paris, has quickly gained recognition since its founding in 2020, thanks to its comprehensive services covering pre-market clinical trials and post-market clinical follow-up (PMCF).
Eclevar stands out for its ability to provide tech-enabled service tailored medtech industry to overcome clinical challenges related to the MDR 2017/745, leveraging an international team of experts, clinical trial platform that speeds site feasability and qualification, patients identification as well as state of the Art eCOA/ePRO platform.
Nathalie MASSON, Director of Innovation & Development at Unither Pharmaceuticals, stated: “Eclevar’s expertise in the design and conduct of clinical studies on medical devices, as well as their knowledge of current regulations, allows us to save valuable time in our developments and feel confident about the acceptability of the studies they design by health authorities. Eclevar is truly attentive to our needs, while also offering valuable suggestions, which is greatly appreciated by our internal R&D teams.”
HACHANI Chems, Executive President of Eclevar MedTech, said: “Working with Unither Pharmaceuticals is an extraordinary opportunity for us. Their commitment to innovation and quality perfectly aligns with our mission to provide top-notch clinical and regulatory solutions. We are excited to contribute to their success and advance the healthcare industry together.”
This strategic collaboration between Unither Pharmaceuticals and Eclevar MedTech promises to bring significant advancements in the development of new treatments and improve the lives of patients worldwide.
Press Contacts:
Unither Pharmaceuticals
Communication Department
Email: communication@unither-pharma.com
Website: www.unither-pharma.com
Eclevar MedTech
Public Relations Department
Email: Cliencare@eclevarmedtech.com
Website: www.eclevarmedtech.com
About Unither Pharmaceuticals:
Unither Pharmaceuticals is a French company specializing in the development, manufacturing, and packaging of pharmaceutical products and medical devices.
About Eclevar MedTech:
Eclevar MedTech is a Paris-based Contract Research Organization (CRO), offering comprehensive services for clinical trials and regulatory compliance in the field of medical devices and in vitro diagnostics.
